FDA OKs New Injectable Type 2 Diabetes Medication

THURSDAY, July 28, 2016 — The injectable drug Adlyxin (lixisenatide) has been approved to treat adults with type 2 diabetes, the U.S. Food and Drug Administration says.
The once-daily injection is to be used along with diet and exercise to improve…
Source: Topamax